Serotonergic modulation of the discriminative-stimulus effects of cocaine in squirrel monkeys.
In order to investigate the potential modulatory role of serotonin on the discriminative-stimulus effects of cocaine, two groups of squirrel monkeys were trained to discriminate 0.3 mg/kg or 1.0 mg/kg cocaine and saline under a two-lever drug-discrimination procedure. Substitution of a range of cocaine doses (0.03-1.7 mg/kg) occasioned orderly, dose-dependent increases in cocaine-lever responding. When administered alone, the non-selective serotonin direct agonist, quipazine, also occasioned increases in cocaine-lever responding which were more pronounced in subjects trained with the lower cocaine dose. When quipazine was administered in combination with cocaine, there was an increase in cocaine-lever responding, indicating an additive effect. The serotonin uptake inhibitor, fluoxetine, occasioned saline-lever responding when administered alone. However, in combination with cocaine, fluoxetine enhanced the discriminative effects of cocaine in subjects trained at the lower cocaine dose. The 5-HT2-selective antagonists, ketanserin and ritanserin, did not occasion cocaine-lever responding when administered alone. In combination with cocaine, ketanserin attenuated the discriminative effects of cocaine in most subjects, and ritanserin attenuated the discriminative effects of cocaine in subjects trained at the higher dose. These results indicate that the discriminative-stimulus effects of cocaine may be increased by direct- and indirect-acting serotonin agonists and attenuated by serotonin antagonists in squirrel monkeys.
Schama
K F
KF
Yerkes Regional Primate Research Center, Emory University, Atlanta, GA 30322, USA.
Howell
L L
LL
Byrd
L D
LD
D000818:Animals; D003042:Cocaine / Q000494:pharmacology*; D004193:Discrimination Learning / Q000187:drug effects*; D004347:Drug Interactions; D007650:Ketanserin / Q000494:pharmacology; D008297:Male; D009294:Narcotics / Q000494:pharmacology*; D011814:Quipazine / Q000494:pharmacology; D012453:Saimiri; D018490:Serotonin Agents / Q000494:pharmacology*
D009294:Narcotics; D018490:Serotonin Agents; D011814:Quipazine; D007650:Ketanserin; D003042:Cocaine